Skip to main content
OTCMKTS:IPATF

ImmunoPrecise Antibodies Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range
$11.05
$18.70
52-Week Range N/A
Volume63,300 shs
Average Volume20,327 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Receive IPATF News and Ratings via Email

Sign-up to receive the latest news and ratings for ImmunoPrecise Antibodies and its competitors with MarketBeat's FREE daily newsletter.


About ImmunoPrecise Antibodies

ImmunoPrecise Antibodies Ltd. engages in the provision of human therapeutic antibody discovery and development services. It offers a selection of antibodies, enzymes, enzymes activity assays, arthritis animal products, proteins, deiminated proteins, and hybridoma licensing for research purposes. Its services include B cell sorting, screening and sequencing; custom, immune and naive phage display production and screening; bi-specific, tri-specific, VHH, and VNAR antibody manufacturing; antibody engineering; and antibody optimization and humanization. The company was founded by Robert Beecroft on November 22, 1983 and is headquartered in Victoria, Canada.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:IPATF
CUSIPN/A
CIKN/A
Phone(250) 483-0308
EmployeesN/A
Year FoundedN/A

Sales & Book Value

Annual SalesN/A

Profitability

Debt

Price-To-Earnings

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable

MarketRank

Overall MarketRank

0.48 out of 5 stars

Medical Sector

1632nd out of 2,039 stocks

Biotechnology Industry

106th out of 157 stocks

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











ImmunoPrecise Antibodies (OTCMKTS:IPATF) Frequently Asked Questions

What stocks does MarketBeat like better than ImmunoPrecise Antibodies?

Wall Street analysts have given ImmunoPrecise Antibodies a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but ImmunoPrecise Antibodies wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are ImmunoPrecise Antibodies' key executives?

ImmunoPrecise Antibodies' management team includes the following people:
  • Jennifer Bath, President, Chief Executive Officer & Director
  • Lisa Helbling, Chief Financial Officer
  • Yasmina Noubia Abdiche, Chief Scientific Officer
  • Stefan Lang, Chief Business Officer
  • Kari Graber, VP-Client Relations & Project Management

Who are some of ImmunoPrecise Antibodies' key competitors?

What is ImmunoPrecise Antibodies' stock symbol?

ImmunoPrecise Antibodies trades on the OTCMKTS under the ticker symbol "IPATF."

How do I buy shares of ImmunoPrecise Antibodies?

Shares of IPATF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ImmunoPrecise Antibodies' official website?

The official website for ImmunoPrecise Antibodies is www.immunoprecise.com.

How can I contact ImmunoPrecise Antibodies?

The company can be reached via phone at (250) 483-0308.


This page was last updated on 5/15/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.